Multiple Sclerosis and Neuromyletis Optica - Clinical Trials
The UC Davis Neurology Department’s faculty members and research staff conduct both basic and clinical research aimed at developing new treatments for Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO).
The participation of our study volunteers in controlled clinical trials has enabled our researchers to help develop new drugs that show promise as future treatments for MS. Patients who would like to assist our ongoing research efforts may be able to participate in clinical trials designed to test these as well as other new therapies for MS and NMO.
Open Studies Currently Enrolling Participants at UC Davis
ACORDA – An intravenous infusion study of rHlgMss in patients with MS immediately following a relapse
For more information, enter NCT02398461 into the search box at www.clinicaltrials.gov.
ASCLEPIOS – A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis
For more information, enter NCT02792218 into the search box at www.clinicaltrials.gov.
ASSESS – A multicenter, randomized, rater- and dose-blinded study to compare the efficacy and safety of 0.25 mg and 0.5 mg of fingolimod with glatiramer acetate 20 mg s.c. in patients with RRMS
For more information, enter NCT01633112 into the search box at www.clinicaltrials.gov.
CHUGAI – A multicenter, randomized, double-blind, placebo-controlled, phase 3 study to evaluate the efficacy and safety of SA237 as monotherapy in patients with Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
For more information, enter NCT02073279 into the search box at www.clinicaltrials.gov.
MEDIMMUNE – A Double-masked, Placebo-controlled Study with Open-Label Period to Evaluate the Efficacy and Safety of MEDI-551 in Adult Subjects with Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders (Protocol CD-IA-MEDI-551-1155)
For more information, enter NCT02200770 into the search box at www.clinicaltrials.gov.
If you are interested in participating or want more information on our clinical trials, please contact:
Janelle Butters, RN, at (916) 734-6276, firstname.lastname@example.org